Inhibitors/antagonists of TGF-β system in kidney fibrosis (Q26852400)

language of work or name

1 reference

October 2012

1 reference

Nephrology Dialysis Transplantation

published in

1 reference

volume

27

1 reference

page(s)

3686-91

1 reference

issue

10

1 reference

Chronic kidney disease progression.

cites work

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS381

Cellular and molecular mechanisms of renal fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS381

Renal interstitial fibrosis: a critical evaluation of the origin of myofibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS381

Epithelial-mesenchymal transition (EMT) in kidney fibrosis: fact or fantasy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS381

Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS381

Dysfunction of fibroblasts of extrarenal origin underlies renal fibrosis and renal anemia in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS381

Insights into the mechanisms of renal fibrosis: is it possible to achieve regression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS381

Reversal of renal disease: is it enough to inhibit the action of angiotensin II?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS381

Activin-like kinase 3 is important for kidney regeneration and reversal of fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS381

Transcriptional control by the TGF-beta/Smad signaling system

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS381

Smad7 as a therapeutic agent for chronic kidney diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS381

Diverse roles of TGF-β/Smads in renal fibrosis and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS381

New pharmacological treatments for improving renal outcomes in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS381

TGF-beta in renal injury and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS381

Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS381

Tubular epithelial-myofibroblast transdifferentiation mechanisms in proximal tubule cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS381

Hyperglycemia and diabetic kidney disease. The case for transforming growth factor-beta as a key mediator

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS381

TGF-beta in diabetic kidney disease: role of novel signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS381

TGF-beta and fibrosis in different organs - molecular pathway imprints

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS381

Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS381

Reversibility of established diabetic glomerulopathy by anti-TGF-beta antibodies in db/db mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS381

Add-on anti-TGF-beta antibody to ACE inhibitor arrests progressive diabetic nephropathy in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS381

Evaluation of anti-TGF-beta2 antibody as a new postoperative anti-scarring agent in glaucoma surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS381

Antifibrotic treatment and other new strategies for improving renal outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS381

Pirfenidone is renoprotective in diabetic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS381

Pirfenidone for diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS381

Bone morphogenetic protein receptors and signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS381

A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS381

Osteogenic protein-1 (bone morphogenetic protein-7) reduces severity of injury after ischemic acute renal failure in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS381

Bone morphogenic protein-7 (BMP-7), a novel therapy for diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS381

BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS381

Bone morphogenic protein-7 inhibits progression of chronic renal fibrosis associated with two genetic mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS381

Bone morphogenetic protein-7 delays podocyte injury due to high glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS381

BMP-7 regulates chemokine, cytokine, and hemodynamic gene expression in proximal tubule cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS381

Bone morphogenic protein-7 inhibits monocyte-stimulated TGF-beta1 generation in renal proximal tubular epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS381

Inhibition of bone morphogenetic protein signaling attenuates anemia associated with inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS381

Direct visualization of Smad1/5/8-mediated transcriptional activity identifies podocytes and collecting ducts as major targets of BMP signalling in healthy and diseased kidneys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS381

USAG-1: a bone morphogenetic protein antagonist abundantly expressed in the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS381

Uterine sensitization-associated gene-1 (USAG-1), a novel BMP antagonist expressed in the kidney, accelerates tubular injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS381

Loss of the BMP antagonist USAG-1 ameliorates disease in a mouse model of the progressive hereditary kidney disease Alport syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS381

Wise, a context-dependent activator and inhibitor of Wnt signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS381

Allelic depletion of grem1 attenuates diabetic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS381

In vivo delivery of Gremlin siRNA plasmid reveals therapeutic potential against diabetic nephropathy by recovering bone morphogenetic protein-7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS381

Mutation and analysis of Dan, the founding member of the Dan family of transforming growth factor beta antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS381

Reduced inflammatory pain in mice deficient in the differential screening-selected gene aberrative in neuroblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS381

A secreted BMP antagonist, Cer1, fine tunes the spatial organization of the ureteric bud tree during mouse kidney development

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS381

The activity of the Nodal antagonist Cerl-2 in the mouse node is required for correct L/R body axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS381

Expression of gremlin, a bone morphogenetic protein antagonist, in human diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS381

Gremlin-mediated BMP antagonism induces the epithelial-mesenchymal feedback signaling controlling metanephric kidney and limb organogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS381

Regulation of mammalian tooth cusp patterning by ectodin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS381

Parathyroid hormone (PTH)-induced bone gain is blunted in SOST overexpressing and deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS381

The organizer factors Chordin and Noggin are required for mouse forebrain development

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS381

Chordin-like 1 and twisted gastrulation 1 regulate BMP signaling following kidney injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS381

Noggin, cartilage morphogenesis, and joint formation in the mammalian skeleton

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS381

Noggin-mediated antagonism of BMP signaling is required for growth and patterning of the neural tube and somite

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS381

Inactivation of mouse Twisted gastrulation reveals its role in promoting Bmp4 activity during forebrain development

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS381

Mammalian twisted gastrulation is essential for skeleto-lymphogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS381

Cv2, functioning as a pro-BMP factor via twisted gastrulation, is required for early development of nephron precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS381

Essential pro-Bmp roles of crossveinless 2 in mouse organogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS381

Kielin/chordin-like protein, a novel enhancer of BMP signaling, attenuates renal fibrotic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS381

Pirfenidone Slows Renal Function Decline in Patients with Focal Segmental Glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS381

Renal Bone Morphogenetic Protein-7 Protects against Diabetic Nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS381

Ramping up endogenous defences against chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS381

Expression of BMP-7 and USAG-1 (a BMP antagonist) in kidney development and injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS381

Renal Fibrosis and Glomerulosclerosis in a New Mouse Model of Diabetic Nephropathy and Its Regression by Bone Morphogenic Protein-7 and Advanced Glycation End Product Inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS381

Recombinant human anti–transforming growth factor β1 antibody therapy in systemic sclerosis: A multicenter, randomized, placebo-controlled phase I/II trial of CAT-192

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS381

7 January 2021

Expression of gremlin, a bone morphogenetic protein antagonist, in glomerular crescents of pauci-immune glomerulonephritis

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS381

7 January 2021

BMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS381

7 January 2021

Inhibition of bFGF-receptor type 2 increases kidney damage and suppresses nephrogenic protein expression after ischemic acute renal failure

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS381

7 January 2021

Neutralization of TGF-beta by anti-TGF-beta antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS381

7 January 2021

Identifiers

DOI

10.1093/NDT/GFS381

1 reference

Consolidated OpenCitations Corpus – April 2017

255669

255669

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference